KZR (Kezar Life Sciences Inc.) Aggregate Asset Value
Kezar Life Sciences (KZR) maintains a strong reputation as a developer of small molecules for combating cancer and autoimmune pathologies due to its deep study of cellular mechanisms. Research efficiency is driven by the automation of synthesis and screening, which reduces manual labor. This price chart illustrates total assets, which amount to 96.62. Business stability is guaranteed by logistics optimization and collaboration with reliable contract laboratories.
Financial and market metric breakdowns for Kezar Life Sciences, Inc (KZR)
- current price and projected stock value:
- business market valuation indicators:
- business book valuation details:
- debt burden and liquidity indicators:
Total Debt to Equity Ratio Kezar Life Sciences|KZR - Long-Term Debt to Capital|Short-Term Debt to Capital Kezar Life Sciences Inc|KZR - Company Total Debt|Debt to Net Assets Ratio Kezar Life Sciences Inc|KZR - Company Long-Term Debts|Short-Term Debt Volume Kezar Life Sciences|Quick Liquidity Indicator kezarlifesciences.com
- earnings and market multiples details:
Summary company analysis:kezarlifesciences.com (KZR)
Total assets, reverse-calculated via ROA, reflect the aggregate resource potential of Kezar Life Sciences (KZR), allowing for a comparison of capital efficiency against market benchmarks. An analysis of total asset dynamics confirms the ability of Kezar Life Sciences (KZR) to maintain the liquidity necessary to complete zetomipzomib trials, where the volume of funds directly determines business sustainability prior to the drug's commercialization and the achievement of key clinical endpoints.
Direct competitors
Total Asset Value of Company ARGX (argenx.com)|BNTX (BioNTech) - Company Total Assets|ABVX: Aggregate Asset Value|Company Total Assets ADMA|Company Total Assets Protagonist Corp (PTGX)|Aggregate Company Assets Immunovant, Inc. IMVT|Aggregate Asset Value KNSA|GRFS - Aggregate Company Assets|Adaptive Biotech (ADPT) - Cumulative Company Assets|CLDX: Company Total Assets|Aurinia Corp (AUPH) - Company Total Assets|Cumulative Company Assets BCRX|VERA: Aggregate Asset Value|Company Total Assets DNTH|Company Total Asset Base Pharvaris NV|Aggregate Company Assets abcellera.com ABCL|TRML - Cumulative Company Assets|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Cumulative Company Assets|Upstream Bio, Inc. (UPB) - Company Total Assets|Aggregate Company Assets Zenas Biopharma, Inc.|Total Business Assets IMNM (Immunome Bio)|Company Total Assets GOSS|KALV - Company Assets|Aggregate Company Assets Septerna SEPN|Company Total Assets Pieris Pharma PVLA|Savara Corp - Company Total Assets|Company Assets Rigel Corp|ANAB (AnaptysBio, Inc.) - Cumulative Company Assets|Total Asset Value of Company ATXS (astriatx.com)|ENGN (enGene) - Company Total Assets|Company Total Assets RAPT Therapeutics Inc.|Aggregate Company Assets Aerovate Therapeutics Inc (JBIO)|ACRS (Aclaris Therapeutics, Inc) - Aggregate Asset Value|Kyverna Therapeutics - Cumulative Company Assets|Aggregate Asset Value TLSA|CABA - Aggregate Company Assets|VTYX: Aggregate Company Assets|THTX: Company Total Assets|AVTX - Company Total Asset Base|ELDN (Eledon Pharmaceuticals) - Company Total Assets|agenusbio.com - Total Asset Value of Company|Company Total Assets CLYM|ZURA - Company Assets|aTyr - Cumulative Company Assets|Aggregate Asset Value ADAG|IMA - Aggregate Company Assets|Company Total Asset Base Shattuck Labs, Inc. STTK|EQ: Company Total Assets|Cumulative Company Assets Connect Biopharma Holdings Limited|IMUX (Immunic Therapeutics) - Company Total Assets|Atara Biotherapeutics Inc (ATRA) - Company Total Asset Base|Company Total Assets IFRX|XFOR - Company Assets|Aggregate Company Assets Adicet Bio, Inc. ACET|CELU: Total Business Assets|INmune Bio Corp - Company Total Assets|Barinthus Biotherapeutics Corp (BRNS) - Cumulative Company Assets|SABS: Company Total Assets|Company Assets akaritx.com (AKTX)|Aggregate Company Assets Enlivex Therapeutics Ltd|Q32 Bio Corp (QTTB) - Company Total Asset Base|Aggregate Company Assets GeoVax Labs Inc (GOVX)|Company Total Assets Edesa Biotech Corp (EDSA)|iBio, Inc. - Cumulative Company Assets|CARM (Carisma Therapeutics Inc) - Total Asset Value of Company|XTLB - Aggregate Company Assets|Aggregate Asset Value BOLT (Bolt Biotherapeutics)|hcwbiologics.com (HCWB) - Aggregate Company Assets|Total Asset Value of Company APVO (Aptevo Therapeutics Inc.)|AIM (AIM ImmunoTech Inc.) - Company Total Assets|ADTX: Aggregate Asset Value|Company Total Assets GRI|Company Total Assets XORTX Therapeutics Inc (XRTX)|Aggregate Company Assets ReShape Lifesciences HIND|Aggregate Asset Value REVB|INDP - Aggregate Company Assets|scinai.com (SCNI) - Cumulative Company Assets|CALI: Company Total Assets|Affimed N.V. (AFMD) - Company Total Assets|Cumulative Company Assets ALLK|HOOK: Aggregate Asset Value|Company Total Assets IGMS|Company Total Asset Base iteostherapeutics.com|Aggregate Company Assets Ocean Biomedical OCEA|TCBP - Cumulative Company Assets|THRD - Aggregate Company Assets